The proteasome ubiquitin receptor hrpn13 and its interacting deubiquitinating enzyme Uch37 are required for proper cell cycle progression

Recently, we reported that bisbenzylidine piperidone RA190 adducts to Cys-88 of the proteasome ubiquitin receptor hRpn13, triggering accumulation of ubiquitinated proteins and endoplasmic reticulum stress-related apoptosis in various cancer cell lines. hRpn13 contains an N-terminal pleckstrin-like receptor for ubiquitin domain that binds ubiquitin and docks it into the proteasome as well as a C-terminal deubiquitinase adaptor (DEUBAD) domain that binds the deubiquitinating enzyme Uch37. Here we report that hRpn13 and Uch37 are required for proper cell cycle progression and that their protein knockdown leads to stalling at G₀/G₁. Moreover, serum-starved cells display reduced hRpn13 and Uch37 protein levels with hallmarks of G₀/G₁ stalling and recovery to their steady-state protein levels following release from nutrient deprivation. Interestingly, loss of hRpn13 correlates with a small but statistically significant reduction in Uch37 protein levels, suggesting that hRpn13 interaction may stabilize this deubiquitinating enzymeinhuman cells. We also find that RA190 treatment leads to a loss of S phase, suggesting a block of DNA replication, and G₂ arrest by using fluorescence-activated cell sorting. Uch37 deprivation further indicated a reduction of DNA replication and G₀/G₁ stalling. Overall, this work implicates hRpn13 and Uch37 in cell cycle progression, providing a rationale for their function in cellular proliferation and for the apoptotic effect of the hRpn13-targeting molecule RA190.